سعر جاكو مانس 60 مجم 3 قرص 2022

Dapoxetine 60 mg film-coated tablets, a short-acting SSRI taken on demand for premature ejaculation.

• Premature ejaculation in adult men aged 18 to 64 years who meet all diagnostic criteria (IELT < 2 minutes, persistent/recurrent, marked distress, poor control, history in most attempts over 6 months); on-demand use only.Population: Men 18-64 yearsLäkemedelsverket (Swedish Medical Products Agency)

• Most common and dose-related: nausea (11.0% at 30 mg, 22.2% at 60 mg), dizziness, headache, diarrhoea, insomnia and fatigue; syncope and orthostatic hypotension have been reported.International label, same formulation · Läkemedelsverket (Swedish Medical Products Agency)

• Significant cardiac conditions: heart failure (NYHA II-IV), conduction abnormalities (AV block, sick sinus syndrome), significant ischaemic or valvular heart disease, or a history of syncope.International label, same formulation · Läkemedelsverket (Swedish Medical Products Agency)
• History of mania or severe depression.International label, same formulation · Läkemedelsverket (Swedish Medical Products Agency)
• Concomitant MAOIs, thioridazine, SSRIs/SNRIs/TCAs or other serotonergic products (e.g., L-tryptophan, triptans, tramadol, linezolid, lithium, St John's wort), or within 14 days of stopping them; these must not be started within 7 days after stopping dapoxetine.International label, same formulation · Läkemedelsverket (Swedish Medical Products Agency)

• Only for men diagnosed with premature ejaculation; investigate other sexual dysfunction first; do not use in men with erectile dysfunction using PDE5 inhibitors.International label, same formulation · Läkemedelsverket (Swedish Medical Products Agency)
• Orthostatic hypotension and syncope (with or without prodromal symptoms) have occurred; perform an orthostatic test before starting and avoid treatment if there is a history of orthostatic reactions; avoid driving or hazardous machinery if prodromal symptoms occur.International label, same formulation · Läkemedelsverket (Swedish Medical Products Agency)
• Avoid alcohol, which may increase neurocognitive effects and the risk of syncope.International label, same formulation · Läkemedelsverket (Swedish Medical Products Agency)

• Monoamine oxidase inhibitorsRisk of serious, sometimes fatal reactions (serotonin syndrome-like); contraindicated within 14 days before and 7 days after dapoxetine.Läkemedelsverket (Swedish Medical Products Agency)
• ThioridazineDapoxetine inhibits CYP2D6 and may raise thioridazine levels, augmenting QTc prolongation; contraindicated.Läkemedelsverket (Swedish Medical Products Agency)
• PDE5 inhibitorsPossible reduced orthostatic tolerance; should not be used together.Läkemedelsverket (Swedish Medical Products Agency)

• Not indicated for use by women; animal studies do not indicate harmful effects on fertility, pregnancy or embryo-fetal development.International label, same formulation · Läkemedelsverket (Swedish Medical Products Agency)
• It is not known whether dapoxetine or its metabolites are excreted in human milk.International label, same formulation · Läkemedelsverket (Swedish Medical Products Agency)

English text not available for this section.